A coordinated investment platform for menstrual conditions and disorders.
MOSAIC aligns philanthropic, public, and private capital around a shared investment logic: identify where promising science, diagnostics, therapeutics, care models, and enabling infrastructure are stalled; match each bottleneck with the right form of capital; and ensure that solutions are designed for both high-income and low-to-middle income markets from the start.
Fragmented funding, organized into a capital architecture that reaches scale.
Menstrual conditions and disorders are among the most overlooked and undercapitalized areas in global health. Innovation is emerging — but it stalls at the same predictable points: clinical validation, provider uptake, reimbursement, and integration into health systems. And the women most affected, particularly across low- and middle-income countries, are too often left out of both the evidence base and the pipeline.
MOSAIC exists to change that trajectory. We map where capital is flowing and where it isn't, identify where promising work is stuck, match each bottleneck with the right form of capital, and bring funders into coordinated action. The result is a platform that lets funders and investors move earlier, move together, and design every solution for high-income and LMIC markets from the start.
Six priority menstrual conditions and disorders.
Heavy Menstrual Bleeding
Pelvic Pain & Dysmenorrhea
PMOS
Polyendocrine Metabolic Ovarian Syndrome
Endometriosis
Adenomyosis
Uterine Fibroids
What success looks like in five years.
By 2030, MOSAIC will have changed how capital moves for menstrual conditions and disorders. Our goal is to shift from a fragmented and underpowered field to one that is coordinated, sequenced, and accountable to the women and girls, worldwide.
Success will be measured by the ability of capital — in all forms — to help promising science move faster into care and bring better solutions within reach for the women who need them most.
Mobilize coordinated capital at scale
Catalyze $100M+ in philanthropic, public, and private capital that is deployed, coordinated, or directly influenced through MOSAIC-aligned opportunities. Our priority is to see a growing share of capital flowing to validation, market access, and systems integration in LMIC settings, in particular.
De-risk market entry so diverse capital can move
Build the validation, reimbursement, guideline, and market-access evidence that lets philanthropic, public, and private capital commit with confidence — shortening the timeline for promising innovations to reach the women who need them.
Widen access for the women most in need
Ensure a growing share of MOSAIC-backed innovations are designed, validated, and adapted for low- and middle-income settings from the start.
Shift the evidence and the systems
Strengthen the guidelines, reimbursement pathways, provider training, data systems, and policy reforms that decide whether innovation becomes standard care by building the evidence base.
Build a durable coalition and field
Grow a coordinated community of 100+ funders and investors, including those new to this space, and establish MOSAIC as a lasting platform with an ongoing pipeline of investable opportunities for menstrual conditions and disorders.
Five functions that turn scattered activity into a coordinated market.
Capital Intelligence
Maintain a live view of where capital is flowing, where it is clustered, and where catalytic gaps remain.
Opportunity Translation
Convert promising science, companies, policy signals, and implementation models into funder-ready investment pathways.
Capital Sequencing
Define which capital is needed when: grants for evidence, catalytic capital for validation, public financing for systems integration, and private capital for scale.
Market Access Design
Build reimbursement, guideline, procurement, and LMIC adaptation pathways before innovations are too far downstream to redesign.
Coalition Execution
Bring funders and investors into coordinated action around specific opportunities rather than broad thematic interest.
Four pillars, one pathway from discovery to scale.
Strengthening the scientific substrate
Foundational and translational research — epidemiology, disorder characterization, biomarker discovery, and early clinical R&D — that everything downstream depends on.
From early signals to validated tools
Moving non-invasive diagnostics, digital measurement, repositioned medicines, and novel treatments through clinical validation, regulatory readiness, reimbursement, and adoption in both high-income and LMIC settings.
Turning innovation into accessible care
The market-access infrastructure that gets solutions to patients: care navigation, provider training, task-sharing, benefits-package design, insurance integration, procurement, and affordability.
Building the conditions for scale
The policy, evidence standards, narrative, and demand that move menstrual conditions and disorders from underrecognized to an actionable public-health and investment priority.
MOSAIC is built for everyone moving this field forward.
We coordinate across the full pathway from discovery to scale — which means there's a role for every kind of partner, whether you bring capital, science, innovation, or delivery. Each brings something distinct; each goes further as part of a coordinated effort.
Philanthropic & catalytic funders
Foundations and family offices funding the science, evidence, and validation that markets won't fund on their own. MOSAIC helps you place catalytic capital where it unlocks the most follow-on investment — and connects each grant to a sequenced pathway toward scale.
Public & multilateral funders
Bilateral, multilateral, and government research funders building the systems layer — reimbursement, guidelines, procurement, and health-system integration. We surface where public financing is the missing piece between a proven innovation and the population it should reach.
Private & impact investors
Venture and impact funds backing diagnostics, therapeutics, and care models. Beyond curated deal flow, MOSAIC offers de-risked opportunities, non-dilutive capital stacked alongside your own, and credible pathways into LMIC markets.
Strategic & corporate partners
Pharma, diagnostics, and femtech companies with the clinical, commercial, and distribution capabilities to bring innovations to market. We connect you to validated science and partnership structures designed for both high-income and LMIC reach.
Researchers
Epidemiologists and population scientists mapping prevalence, risk, and the evidence base. MOSAIC links your findings to the funders and pathways that can act on them, and helps turn research into guideline- and policy-relevant evidence.
Scientists & clinicians
Bench scientists and frontline clinicians advancing diagnostics, therapeutics, and care. MOSAIC connects your work to validation funding, real-world testing sites, and the partners needed to move from proof to practice.
Founders & innovators
Companies and inventors building diagnostics, devices, therapeutics, and care models. MOSAIC opens routes to non-dilutive capital, clinical and market-access pathways, and adaptation for both high-income and LMIC settings.
Implementers
Health systems, NGOs, and delivery organizations bringing solutions to patients. MOSAIC helps you reach financing, provider-training models, and the procurement and integration pathways suited to your context.
Wherever you fit in this picture, the form below is where to start the conversation.
Orchestrated by Bitton Global Advisory
For too long, the pain of women and girls with menstrual conditions and disorders has been silenced, misunderstood, and met with too little care, attention, and investment. That ends now. Join us.
Partner with MOSAIC.
Tell us a little about your organization and what you're working on or exploring. A MOSAIC team member will follow up with you directly.